|[January 09, 2013]
Research and Markets: Cervical Cancer Global Clinical Trials Review, H2, 2012 Features Players such as Pfizer Inc. and Bristol-Myers Squibb Company
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/3wxrv7/cervical_cancer)
has announced the addition of GlobalData's new report "Cervical Cancer
Global Clinical Trials Review, H2, 2012" to their offering.
The clinical trial report, Cervical Cancer Global Clinical Trials
Review, H2, 2012" provides data on the Cervical Cancer clinical trial
scenario. This report provides elemental information and data relating
to the clinical trials on Cervical Cancer. It includes an overview of
the trial numbers and their recruitment status as per the site of trial
conduction across the globe. The databook offers a preliminary coverage
of disease clinical trials by their phase, trial status, prominence of
the sponsors and also provides briefing pertaining to the number of
trials for the key drugs for treting Cervical Cancer. This report is
built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by Our team of
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the
clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Merck & Co., Inc.
Eli Lilly and Company
Helix BioPharma Corp.
Zeria Pharmaceutical Co Ltd
N.V. Mithra Pharmaceuticals S.A.
Preventive Oncology International Inc
Novartis Pharmaceuticals Corporation
Taiho Pharmaceutical Co., Ltd.
Bristol-Myers Squibb Company
Nippon Kayaku Co., Ltd.
Precision Therapeutics, Inc.
Hoffmann-La Roche Inc.
Daiichi Sankyo Company, Limited
Chang Gung Memorial Hospital
Korea Cancer Center Hospital
For more information visit http://www.researchandmarkets.com/research/3wxrv7/cervical_cancer
Source (News - Alert): GlobalData
[ Back To Technology News's Homepage ]